Surgical Blades Market Share Provides In-Depth Analysis of the Industry, With Current Trends and Future Estimations to Elucidate The Investment Pockets

Overview

Market Research Future (MRFR) announces the publication of its research report Global Surgical blades Market, 2019–2025. The global surgical blades market was valued at USD 346 million in 2018 with the CAGR of 7.4% during the forecast period of 2019–2025.

Surgical blades are the instruments used for tissue dissections and skin incisions at the time of surgery. Surgical blades are available in sterile and non-sterile form of packaging. Surgical scalpel can be disposable or reusable. Reusable scalpels have permanently attached blades that can be sharpened during surgery. Disposable scalpels are used once at a time and have plastic handle attached to it. Various types and size of blades are available depending upon the type of surgical procedures and treatment.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/8107

Segmentation

The global surgical blades market has been segmented based on product type, material, end user.

The market, based on product type, has been bifurcated into sterile and non-sterile surgical blade.  The sterile surgical blade market is expected to hold a major share in the market. As there is increase in demand by the physicians globally. Non-sterile surgical blade is expected to be the fastest growing as the scalpel blades are also available in non-sterile form of packaging.

The market, by material, has been classified as stainless steel, high grade carbon steel. Among these, stainless steel segment is the largest in terms of value and is predicted to achieve more revenue in the upcoming market. Whereas high grade carbon steel is anticipated to be the fastest growing because of increase in availability in various regions.

The market, by end user, has been divided into hospital, clinics, nursing centres. The hospitals segment is the largest end users of surgical blades and is expected to hold a major share throughout the globe. The ambulatory segment is expected to be the fastest growing due to the increased patient population in recent years. For example- According to the National Health Statistics Report approximately 47.2 million surgeries were performed in the Ambulatory centres

Key Players

Some of the Key Players in the global Surgical Blades Market Share are Hillrom Services Inc, Swann Morton Limited, Kai Corporation, Huaiyin Medical Instruments Co., Ltd, Shanghai Medical Instruments (Group) Ltd., Surgical Specialties Corporation, Hu-Friedy, GEISTER MEDIZINTECHNIK GmbH, PL Medical Co., LLC, KAWAMOTO CORPORATION, MANI, INC

 Regional Analysis

Based on region, the market is divided into Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical blades market in the Americas has further been divided into North America. Within North American, market is been further bifurcated into the US and Canada. The European surgical blades market has been sub-classified into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, Italy, Spain, UK, and the rest of Western Europe. The surgical blades market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and Rest of Asia-Pacific. The surgical blades market in the Middle East & Africa has been classified into the Middle East and Africa.

 Browse Full Report Details @ 

https://www.marketresearchfuture.com/reports/surgical-blades-market-8107

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Elastography Imaging Market Share Insights By Growth, Opportunities, Trends, Drivers, Challenges, Forecast

It is estimated that the global elastography imaging market is expected to register a CAGR of 11.1% during the forecast period of 2019 to 2025, with a market value of USD 2,538.2 million in 2018. Elastography is a medical imaging method that plots the elastic properties of soft tissue to stipulate the diagnostic data during surgery. The elastography imaging market is fueled by numerous factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, along with the rising prevalence of life-threatening diseases. However, the high cost of the systems is expected to curb the growth of the elastography imaging market.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/8070

The global elastography imaging market is currently dominated by numerous market players. The key players are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in February 2019, Esaote launched the MyLabX8, an ultrasound platform to support hospitals and clinics. Also, in November 2018, Canon Medical Systems Corporation introduced Contrast Vector Imaging (CVI) to provide additional information on liver hemodynamics and expand the use of contrast-enhanced ultrasound on its premium ultrasound system. 

Segmentation

The global Elastography Imaging Market Share has been segmented based on modality, application, and end user.

The market, based on modality, has been bifurcated into ultrasound, and magnetic resonance elastography. The ultrasound segment is expected to hold a major share in the market, owing to the high advantages of this type of modality. The magnetic resonance elastography segment is anticipated to be the fastest growing due to the wider availability and rising adoption rate.

The market, by application, has been divided into radiology/general imaging, cardiology, obstetrics/gynecology, urology, vascular, orthopedic & musculoskeletal applications, and others. The radiology/general imaging segment is expected to hold a major share owing to the increasing occurrences of chronic diseases throughout the globe. The cardiology segment is expected to be the fastest growing one due to the increased patient population in recent years.

The market, by end user, has been classified as hospitals & ambulatory surgical centers, diagnostic centers, research laboratories, and others. The hospitals & ambulatory surgical centers segment is anticipated to hold a major share in the market. This is due to the increasing number of hospitals as well as the increased number of hospitalizations. The diagnostic centers segment is expected to boom and becomes the fastest growing market due to the increased patient preference and inclination towards the diagnostic centers.

Key Players

Some of the key players in the global elastography imaging market are Canon Medical Systems Corporation, Siemens AG, Fujifilm Holdings Corporation, Esaote, Resoundant Inc., Hitachi Ltd., Mindray Medical International Ltd., Koninklijke Philips N.V., Samsung Electronics (Samsung Medison), Supersonic Imagine, and General Electric Company.

Regional Analysis

The market in the Americas is likely to lead the global elastography imaging market during the assessment period owing to the increasing per capita healthcare expenditure, and the heavy adoption of new technology in the region. Additionally, the increase in the insurance coverage and improving reimbursement scenario in the US and Canada are also projected to drive the growth of the market.

Europe is expected to hold the second largest position in the global elastography imaging market. The market growth in this region is because of the presence of a well-established healthcare system, an increase in life-threatening diseases, and the active involvement of major players. For instance, in May 2017, Esaote expanded its ultrasound sales team in the UK.

The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to the increasing number of patients with chronic diseases and government initiatives for healthcare reforms. However, a decrease in capital investment is restricting the market growth of this region.

The market in the Middle East & Africa is likely to account for the smallest share of the global elastography imaging market. The market growth in this region is restricted due to the low per capita disposable income.

For More Details

https://www.marketresearchfuture.com/reports/elastography-imaging-market-8070

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Urinary Drainage Bags Market Share| Growth Rate, Industry Size, Share, Trends, Growth Factors

Market Highlights

Global urinary drainage bags market expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 142.54 million in 2018 and is projected to grow at a CAGR of 6.8% over the forecast period. Urine drainage bags collect urine. Urine bags are attached to a catheter (tube) that is inside the bladder. The need for a catheter and urine drainage bag is because of urinary incontinence (leakage), urinary retention (not being able to urinate), a surgery that made a catheter necessary, or another health problem. The urinary drainage bags market is growing at a significant growth rate, the major factors influencing the growth of the market include; growing urinary infectious diseases, increase in a number of urological and gynecological surgeries, increasing prevalence of urinary incontinence, increasing geriatric population.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/8058

Urinary incontinence is one of the rising urology diseases in the elderly population.  Age is a major risk factor for several physical, mental, and economically devastating health disorders. Alzheimer’s disease is a type of dementia that causes debilitating problems with memory, thinking, and behavior. Alzheimer’s disease often has problems with urinary incontinence.

According to the World Population Prospects by the United Nations, approximately 962 million older population aged 60 and above were present globally as of 2017. This represents about 13% of the global population. Additionally, according to WHO, it is estimated that the world’s population aged 60 years and older are likely to double from 12% to 22% by 2050. This increasing geriatric population is further increasing urology disease and influencing the growth of urinary drainage bags market.

Segmentation

The global Urinary Drainage Bags Market Share has been segmented into type, usage, and end user.

Based on type, market segmented into large bags, and leg bags

On the basis of usage, the market is segmented into reusable urinary drainage bags, disposable urinary drainage bags

Based on end user, the urinary drainage bags market is segmented into hospitals and clinics, surgical centers, and others.

Key Players

Some of the major players operating in the global urinary drainage bags market are Coloplast, Cook Medical, C. R. Bard, Inc., Amsino International, Inc., Medline Industries, Inc., Moore Medical LLC, Flexicare Medical Limited, Plasti-med and Teleflex Incorporated, Pacific Hospital Supply Co. Ltd., and Covidien.  

Regional Analysis

Geographically the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Geographically, the Americas is anticipated to dominate the global urinary drainage bags market owing to the presence of the major manufacturers, high healthcare expenditure, huge patient population. Europe is expected to hold the second largest position in the global urinary drainage bags market. Asia-Pacific is the fastest growing urinary drainage bags market owing to the increasing elderly population, rapidly improving healthcare reforms and the presence of a huge patient pool. The Middle East and Africa market for urinary drainage bags is expected to grow at a steady.

Browse Full Report Details @ 

https://www.marketresearchfuture.com/reports/urinary-drainage-bags-market-8058

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Medical Oxygen Concentrators Market Trends Including Top Key Players, Trends And Emerging Growth Factors

Market Highlights

The Global Medical Oxygen Concentrators Market held a market value of USD 1,755.8 Million in 2018 and is Projected to Grow at a CAGR of 7.8% Over the Forecast Period. Oxygen concentrator, also called as oxygen generator is a medical device used to deliver oxygen to the patient. This device concentrates the oxygen from a gas supply by removing nitrogen to supply an oxygen-enriched product gas stream. Stationary oxygen concentrators are used as stationary sources to provide long-term oxygen therapy (LTOT) to patients at home. Oxygen concentrators provide supplementary oxygen for patients suffering from a chronic obstructive pulmonary disease (COPD) and in higher concentrations for pulmonary edema and severe chronic hypoxemia. In addition, this device is also used as an adjunct treatment for severe sleep apnea.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/7876

Portable oxygen concentrators are oxygen machines that draw in oxygen with the use of a battery, electricity or DC power. These oxygen concentrators offer advantages such as compact in size, lightweight, improved efficiency, cost economic price, and mobility that enables patients to travel hassle-free. Technological advancements in the portable oxygen concentrators include pressure swing adsorption (PSA), and membrane technology is helping in the swift adoption of portable medical oxygen concentrators.

Segmentation

The global medical oxygen concentrators market has been segmented into product, technology, indication, end user, and region.

By product, the market has been segmented into portable oxygen concentrators and stationary oxygen concentrators.

On the basis of technology, the market has been divided into the continuous flow and pulse dose.

Based on indication, the market has been categorized into chronic obstructive pulmonary disease, asthma, sleep apnea, and others.

By end user, the market has been classified into homecare, travel, hospitals and clinics, and others. Home oxygen concentrators facilitate convenience and make it easier and safer for the patient to complete their day-to-day activities, which is supporting the dominance of the homecare segment during the next six years.

Key Players

Few of the prominent players in the global medical oxygen concentrators market are Philips Healthcare, AirSep Corporation, Invacare Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed, Chart Industries, Inc., Nidek Medical Products, Inc., Inogen, Precision Medical, Inc., GCE Group, Besco Medical Limited, O2 Concepts, LLC, Teijin Limited, and OSI – Oxygen Solutions Inc.

Regional Analysis

The global Medical Oxygen Concentrators Market Trends has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of favorable government initiatives, reimbursement policies, and major market participants developed home healthcare care services and higher adoption of portable oxygen concentrators for homecare needs. Higher value contributors based in the US are Philips Healthcare, Invacare Corporation, AirSep Corporation, ResMed, and Precision Medical, Inc. In addition, government initiatives including the presence of the Federal Aviation Administration (FAA), which authorize the use of portable concentrators during air travel are promoting the dominance of the Americas.

Europe would follow the Americas in terms of revenue over the forecast period as the German government has been undertaking several initiatives to reduce pollution levels in the country and promote public health. In November 2018, the German government unveiled a 5-point plan to reduce plastic waste.

The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period. This is owing to rising prevalence of COPD and asthma, increasing spending on healthcare, growing awareness about state-of-the-art technologies in an oxygen concentrator, rising adoption of portable units, growth in disposable income, and changing diet pattern and lifestyle resulting in the development of diseases. As per data published in The Lancet journal, in 2016, the prevalence of COPD in India was 4·2% and the prevalence of asthma 2·9%. India has a higher prevalence of COPD than the global average, as well as more disability-adjusted life-years (DALYs) per person with COPD or asthma than the global average.

The Middle East & Africa has the least share of the global medical oxygen concentrators market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Browse Full Report Details @ 

https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Minimally-Invasive Surgery Devices Market Trends Will Grow at CAGR During Forecast Period Global Evaluation by Trends

Market Highlights

Global minimally-invasive surgery devices market expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 20093.4 Million in 2018 and is Projected to Grow at a CAGR of 9.8% over the forecast period. The global minimally-invasive surgery devices market is growing at a rapid pace, the major factor influencing the growth of the market include; increasing geriatric population, increasing prevalence of chronic diseases. Chronic disease has been one of the major application of minimally-invasive surgery device.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/7875

Chronic diseases and conditions are on the rise worldwide. As said by the World Health Organization (WHO), the amount of the burden of chronic diseases is expected to escalate to 60% by 2020 and 79% of deaths due to these diseases would occur in developing countries. According to a 2016 study published in “The Journal of Pediatrics,” it is observed that among the US population functional constipation and abdominal migraine are the most frequently occurring gastrointestinal disorders in children and adolescents. The occurrence of functional constipation is dominated in females than in males.

Moreover, as per the Centers for Disease Control and Prevention, in 2015, an estimated 1.3% of the US adults reported being diagnosed with irritable bowel syndrome (IBD) (Either Crohn’s disease or ulcerative colitis). In accordance with the Cancer Research UK, about 1590 new cases of small intestine cancer were reported in the UK in 2015. The incidences of obesity and urological diseases have also increased in recent years. According to WHO, in 2016 over 1.9 billion adults were obese. More than one-third of the adult population in the US has obesity. Additionally, WHO stated that over 50% of the women are reported to have the urinary tract infection at some point in their lives. With the increasing incidences of diseases, the demand for the minimal-invasive procedure is also expected to increase which leads to driving the global minimal-invasive devices market.

Segmentation

The Global Minimally-Invasive Surgery Devices Market Trends has been segmented into type, application and end user.

Based on type, market segmented into handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, and others.

based on application, the minimally-invasive surgery devices market is segmented into cardiac surgery, gastrointestinal surgery, orthopedic surgery, vascular surgery, gynecological surgery, urological surgery, thoracic surgery, cosmetic surgery, dental surgery, and others.

Based on end user, minimally-invasive surgery devices market segmented into hospitals & clinics, ambulatory surgical centers, and others.

Key Players

Some of the major players operating in the Global Minimally-Invasive Surgery Devices Market are Abbott,

Intuitive Surgical, Inc, Fortimedix Surgical, Siemens Healthcare GmbH, GE Healthcare, Medtronic, Inc, Ethicon, Inc., ArthroCare Corporation, KEBOMED Europe AG, DePuy Synthes, NuVasive, Inc., Biomet, Inc, Norwood Medical, Freudenberg Medical, and others.

Regional Analysis

Geographically the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Geographically, the Americas is anticipated to dominate the global minimally-invasive surgery devices market owing to the presence of a huge patient population, high healthcare expenditure, well-developed technology, and the presence of the leading players. Moreover, increasing government support for the development of the advanced devices and well-developed healthcare sector have provided support for the growth of the minimally-invasive surgery devices market in America. Europe is expected to hold the second largest position in the global minimally-invasive surgery devices market. Asia-Pacific is the fastest growing minimally-invasive surgery devices market owing to the increasing need for better monitoring devices, rapidly improving technology and the presence of a huge patient pool. The Middle East and Africa market for minimally-invasive surgery devices is expected to grow at a steady.

Browse Full Report Details @ 

https://www.marketresearchfuture.com/reports/minimally-invasive-surgery-devices-market-7875

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Vaginal Slings Market Share Worldwide Industry Share, Size, Gross Margin, Trend, Future Demand and Forecast

Overview

Vaginal sling procedures are defined as types of surgeries that can help to control stress urinary incontinence. A new report on the global vaginal slings market, published by Market Research Future (MRFR), infers that this market could mark improvement at 3.6 % CAGR between 2017 and 2023. In terms of value, the market can be worth USD 1,459 Mn by the end of the forecast period.

Major market driving factors of the global vaginal slings market include the aging female population, increasing research to discover new urinary incontinence treatment options, rising occurrence of urinary incontinence. However, the complications caused by urinary incontinence surgery and various recent product recall can hinder the market growth.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/7888

Market Segmentation

The global vaginal slings market segmentation encompasses end-user, method, and product type. MRFR’s take on the market explores various facets of the market in-depth.

Regarding end-users, this market has been segmented into ambulatory surgery centers, hospitals, urogynecology clinics, and others. The hospitals segment can be worth USD 539.7 Mn by 2023.

In the context of method, the market has been segmented into the retropubic method, single-incision mini method, and transobturator method.

Based on product type, the market has been segmented into mini-slings/single-incision slings, tension-free vaginal tape slings (TVT), transobturator tape slings (TOT), and others. The TVT segment holds the 52% market share in the global vaginal slings market.

Regional Segmentation

A geographical outlining of the global Vaginal Slings Market Share covers Europe, The Americas (North America & Latin America), Asia Pacific, and the Middle East & Africa (MEA).

During the forecast period, the Americas region is expected to hold the largest market share in the global market due to the increasing awareness and the rising prevalence of urinary incontinence among the female population. Availability of advanced medical facilities in the USA and Canada is also boosting the market growth. Due to this reason, North America is the bigger regional market segment, compared to Latin America.

During the forecast period, the European market is likely to grow substantially due to increased healthcare spending and increasing awareness related to urinary incontinence issues. Due to the reasons the same as The Americas, Western Europe is a bigger regional market segment compared to Eastern Europe. Germany holds a 27% share in the market of Western Europe. Other pressing country-specific markets in this region are France, Italy, Spain, and the UK. An analysis of the remaining countries in Western Europe featured in this report estimates the huge contribution to market revenue from some other countries, along with and a sizable revenue contribution from Eastern Europe.

During the forecast period, the Asia Pacific region can stand as the fastest growing regional market due to the development of new infrastructure to support the healthcare industry and the presence of a large number of research organizations. The largest country-specific markets in this region are Australia, China, India, Japan, and South Korea. An analysis of the remaining countries in the Asia Pacific region featured in this report anticipates the huge contribution to market revenue from some other countries. The MEA region is expected to show the least amount of growth due to the lack of adequate healthcare spending and low per capita income.

Key Players

Major players in the global vaginal slings market include A.M.I. GmbH (Austria), Betatech Medical (Turkey), Boston Scientific Corporation (USA), CL Medical (France), Coloplast Corp (Denmark), Ethicon Inc. (USA), Herniamesh S.r.l. (Italy), and Promedon (Argentina).

Access Report Details @ 

https://www.marketresearchfuture.com/reports/vaginal-slings-market-7888

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Transcatheter Embolization and Occlusion Devices Market Dynamics Global Analysis, Research, Review, Applications and Forecast

Market Highlights

The Global Transcatheter Embolization and Occlusion Devices Market held a Market Value of USD 3,290.4 million in 2018 and is Projected to Grow at a CAGR of 9.9% Over the Forecast Period. A catheter embolization procedure involves medications, or synthetic materials (embolic agents) are inserted through a catheter into a blood vessel to prevent blood flow to the area. Factors contributing to the market growth are technological advances in the products, expansion of the target patient population base, surging number of minimally invasive surgeries, the presence of favorable reimbursement for cardiovascular surgeries. On the other hand, costlier products and the presence of stringent regulatory framework for product commercialization are anticipated to limit the market growth during the next five years.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/7864

Transcatheter embolization and occlusion (TEO) is a minimally invasive alternative to an open surgery thereby shifting the preference of patients towards minimally invasive surgeries as it offers several advantages including minor incisions & tissue damage, minimal pain & surgical scars, same day discharge from the healthcare settings, and speedy wound healing. Overall, this can cause minor complications and reduces surgery costs that are likely to foster market growth during the next nine years.

Technology is proving its efficiency in treatment while performing complex surgeries. Embolization technique has become one of the most popular modalities for treatment of various types of cancer such as kidney, breast, liver (hepatocellular carcinoma), pancreatic, among others.

The introduction of technically advanced products with enhanced efficiency to treat malformations and fibrosis is supporting the market growth. For instance, in January 2018, the Cerenovus division of Johnson & Johnson Services, Inc. introduced the Galaxy G3 Mini embolic coil to remove clots from brain post ischemic strokes.

Key Players

Few of the prominent players in the global Transcatheter Embolization and Occlusion Devices Market Dynamics are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Terumo Corporation, Pfizer Inc., DePuy Synthes, Cardinal Health, Cook Medical, Sirtex Medical Limited, and Merit Medical Systems.

Regional Analysis

The Global Transcatheter Embolization and Occlusion Devices Market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of medical reimbursements for cardiovascular procedures and key original equipment manufacturers which facilitates early market initiation, established healthcare infrastructure, and skilled healthcare professionals. These players include Stryker Corporation, Boston Scientific Corporation, Pfizer Inc., Abbott Laboratories, and Cardinal Health.

Europe would follow the Americas in terms of value in the transcatheter embolization and occlusion devices market as medical devices make an essential contribution to healthcare in the European Union for the benefit of European citizens. In addition, strong growth in radioembolization spheres, drug-eluting beads, and flow-diverting devices would support the regional market growth.

The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period owing to growing geriatric population coupled with rising burden of venous malformations and vascular anomalies, rapidly growing medical tourism in emerging countries including India, Australia, China, and Malaysia.

The Middle East & Africa has the least share of the global transcatheter embolization and occlusion devices market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Segmentation

The global transcatheter embolization and occlusion devices market has been segmented into product, indication, end user, and region.

By product, the market has been segmented into coiled devices and non-coiled devices. The coiled devices segment has been further categorized into pushable coils and detachable coils. The non-coiled devices segment has been additionally divided into flow diverting devices, embolization particles, liquid embolic, other embolization and occlusion devices, and accessories. The accessories segment is expected to hold the largest share among non-coiled devices throughout the forecast period due to the introduction of various accessories along with the wide availability of embolization products.

On the basis of indication, the market has been divided into peripheral vascular disease, oncology, neurology, urology, and others.

Based on end user, the market has been categorized into hospitals and clinics, ambulatory surgery centers (ASCs), and others.

Access Report Details @ 

https://www.marketresearchfuture.com/reports/transcatheter-embolization-and-occlusion-devices-market-7864

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Consulting Services Market Share Including Top Key Players, Trends And Emerging Growth Factors

The Global Healthcare Consulting Services Market is expected to register a CAGR of 10.4% during the forecast period of 2019 to 2024. Healthcare consulting services is an essential tool which are used in various healthcare centers. These services help in patient management in hospitals, product launching in healthcare industry and used in data management. It also, helps to maintain connection between the patient and healthcare staff.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/7860

There is a high demand of healthcare consulting services in hospitals, clinics, healthcare companies, and other healthcare facilities. The key factors contributing for the market growth are growing awareness about the patient safety, rising demand for best practices in hospitals and healthcare centers, and rising government regulation regarding patient safety boosts the market growth.

Key Players
Accenture Consulting (US), McKinsey and Company (US), Cognizant (US), Deloitte Consulting (US), Ernst and Young (UK), Bain and Company (US), Deloitte Touche Tohmatsu Limited (US), Huron Consulting (US), KPMG (Switzerland), PWC (UK), The Boston Consulting Group (US)


Segmentation

The Global Healthcare Consulting Services Market Share is segmented on the basis of type of service, component, application, and end user.

Based on the type of service, the global healthcare consulting services market is categorized into IT consulting, digital consulting, financial consulting, operations consulting, and strategy consulting.

Based on the component, the global healthcare consulting services market is segmented into services, software, and hardware.

Based on application, the market is segmented into operations management, financial, population health, and clinical.

Based on operations management, the market is sub segmented into demand forecasting, workforce planning and scheduling, inpatient scheduling, and outpatient scheduling. Based on population health the market is sub segmented into population risk management, patient engagement, population therapy management, and others.

On the basis of finance, the market is sub segmented into revenue cycle management, fraud detection, and others. Based on clinical the market is sub segmented into quality benchmarking, patient care enhancement, and clinical outcome analysis and management.

On the basis of the end user, the market is segmented into hospitals and clinics, life science companies, and government bodies.

On the bases of region, the market is segmented into Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is expected to hold the largest market share and the Middle East and Africa with the low market share during the forecast period.

Regional Analysis
The Americas dominate the global healthcare consulting services market owing to the increase in healthcare infrastructure, growing awareness about the patient safety methods and increasing competition in healthcare companies opts for healthcare consultants for various solution and strategies which increases the demand for healthcare consulting services within the region.

Europe is second in the global healthcare consulting services market owing to increasing adaption of IT services in healthcare and increasing awareness about the healthcare consulting services is promoting the market across the globe.

The Asia-Pacific region is the fastest growing market owing to the increasing patient population, rising demand for various healthcare facilities for better treatment and increasing healthcare expenditure drives the market with the region. The Middle East & Africa has the least share in the global healthcare consulting services market owing to the presence of poor economies and low per capita income, especially in the African region.

For More Details @ https://www.marketresearchfuture.com/reports/healthcare-consulting-services-market-7860

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Cardiovascular Information System (CVIS) Market Share Worldwide Industry Share, Size, Gross Margin, Trend, Future Demand and Forecast

Overview

The global Cardiovascular information system (CVIS) market size is poised to reach the valuation of USD 1,343.26 million by 2025, as per the latest report by Market Research Future (MRFR). The market can grow immensely at 8.30% CAGR over the forecast period (2018-2025).

High prevalence of cardiovascular diseases (CVDs) and disorders is the primary driver of the market. As per the 2015 report by the World Health Organization (WHO), nearly 17.7 million died as a result of CVDs. This has triggered the need for advanced systems in hospitals to reduce the mortality rate. In addition, government initiatives to digitize patient data is likely to bode well for the cardiovascular information system (CVIS) market. Implementation of the electronic health records (EHR) system can make it easy for doctors and physicians to lead to faster diagnosis of diseases.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/7721

Technological developments in healthcare IT has led to the launch of CVIS platforms which can be accessed remotely. This offers scope for doctors to diagnose and prescribe accurate suggestions to patients. Recent upgrades to CVIS has made it possible for different departments in the cardiology section to share and exchange information on a single platform.

The high costs associated with CVIS which can lead to hesitation towards adoption among hospitals can pose a challenge to the market growth.

Segmentation Analysis

The Cardiovascular Information System (CVIS) Market Share is segmented by component, deployment, application, and end-user.

By component, software held close to 67.9% share of the CVIS market in 2017, followed by services the second largest market and hardware the least market share. The software segment is expected to reach a valuation of USD 930.65 million by 2025 due to the software being able to provide clinical data to patients and doctors in real-time. Services, on the other hand, can aim to grow at a steady pace by the end of the forecast period due to constant maintenance and upgradation of CVIS to ensure a smooth workflow in clinics and hospitals.

By deployment, web/cloud-based held the largest market share in 2017, while the on-premise segment held second largest share. The web/cloud-based CVIS is projected grow at fastest CAGR during the forecast period due to low capital investment and scalability of operations. In addition, the ease it provides in reporting information and causing minimal clinical efficiencies can lead to its adoption. On the other hand, on-premise segment accounted for the least market share due to high expenses in maintaining servers, software, and hardware.

Among applications, cardiac and peripheral catheterization held 32.4% share in 2017, followed by echocardiography, hemodynamics monitoring, electrophysiology, vascular ultrasound, nuclear cardiology, ECG/stress/Holter management, and others. Cardiac and peripheral catheterization can increase its market share by the end of the forecast period due to its extensive use in early diagnosis and treatment of congenital disorders. On the other hand, echocardiography is predicted to attain second largest share, this can be attributed to its utilization in detecting abnormal heart valves and other heart defects.

Regional Analysis

Region-wise, the cardiovascular information system (CVIS) market covers the upcoming trends in Europe, Asia Pacific (APAC), Americas, and the Middle East & Africa (MEA). The Americas accounted for 37.6% market share in 2017, followed by Europe, APAC, and MEA.

The Americas CVIS market is expected to reach a valuation of USD 481.04 million by 2025. This can be attributed to sophisticated healthcare infrastructure and adoption of latest systems for streamlining workflow in hospitals. The use of mHealth and big data for detecting CVDs at a preventive stage by clinicians is projected to augur well for the market.

Europe, on the other hand, is predicted to grow at a steady pace due to increased funding by governments and private organizations to improve treatment facilities in cardiology departments in hospitals. Moreover, digitization of patient data is expected to be a positive indicator for the growth of the market.

Competitive Analysis

Key vendors in the cardiovascular information system (CVIS) market include Carestream Health (U.S.), Scimage, Inc. (U.S.), Koninklijke Philips N.V. (The Netherlands), Cerner Corporation (U.S.), Epic Systems Corporation (U.S.), Digisonics Inc. (U.S.), Fujifilm Holdings Corporation (Japan), LUMEDX (China), Agfa-Gevaert N.V. (Belgium), IBM Health (U.S.), General Electric Company (U.S.), McKesson Corporation (U.S.), and Siemens Healthineers (Germany).

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/cardiovascular-information-system-market-7721

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Drug Discovery Informatics Market Share Global Analysis, Research, Review, Applications and Forecast

The global drug discovery informatics market held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% over the forecast period. Drug discovery and development is an extremely complex process requiring the generation of very large amounts of information data and. As the pharmaceutical and biotechnology industry is on the rise, information technology is supporting the drug discovery process to improve research productivity and success rates. Patent expiry of blockbuster drugs, an over-reliance on high throughput discovery strategies, and ongoing industry consolidation through mergers and acquisitions (M&A) are fueling the demand for drug discovery informatics. Few of the market growth factors include a worldwide rising focus on drug discovery, growing need to control drug discovery and development costs, rising research and development (R&D) expenditure, and increasing burden of chronic diseases.

Request Sample Copy:

https://www.marketresearchfuture.com/sample_request/7831

Introduction of in-silico tools that facilitate computation with varied workflows that are in sync with the rate of modern medicinal chemistry is one of the key trends augmenting market growth. It involves different steps and procedures which depend on in-silico tools for reducing the complexity of the process. In-silico tools include modeling tools for the determination of 3D structures of ligand and protein-absorption, distribution, metabolism, excretion, and toxicity (ADMET) assessment-affinity estimation in docking and drug-ligand interaction for pharmacological profiling.

Regional Analysis

The global Drug Discovery Informatics Market Share has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is expected to hold higher market share over the forecast period pertaining to the presence of market value contributors, burgeoning pharmaceutical and biotechnology vertical, and rising prevalence of chronic diseases in the US and Canada. For instance, as per statistics published by the Center for Disease Control and Prevention (CDC), about 610,000 people die due to heart disease in the US every year (one in every four deaths).

Europe would follow the Americas in terms of value in the drug discovery informatics market owing to a surge in the clinical discovery ventures coupled with various activities conducted by research institutes, universities, and centers. The federal government acts as a regulator and also insures some public employees in Germany. Around 16 states in this county maintain public hospitals. The German government also proposes many healthcare programs to make citizens aware of the fatal disease.

Asia-Pacific would represent the fastest market growth during the forecast period owing to growing geriatric population coupled with rising prevalence of chronic diseases, increasing awareness and high adoption of drug discovery informatics, and surging number of clinical trials studies in the region.

The Middle East & Africa has the least share of the global drug discovery informatics market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Segmentation

The global drug discovery informatics market has been segmented into product, mode, service, end user, and region.

By product, the market has been segmented into discovery informatics and development informatics.

On the basis of mode, the market has been divided into in-house informatics and outsourced informatics. 

By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.

Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.

Key Players

Few of the foremost players in the global drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.

Access Full Report @ 

https://www.marketresearchfuture.com/reports/drug-discovery-informatics-market-7831

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com